SLR Investment Corp(NASDAQ:SLRC)
Solar Capital Ltd. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and ...
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2010-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
investment income: | ||||||||||
interest and dividends: | ||||||||||
companies more than 25% owned | 11,675,000 | 11,669,000 | 11,354,000 | 10,474,000 | 2,926,000 | 804,000 | 1,362,000 | 1,082,000 | ||
companies 5% to 25% owned | 248,000 | 3,189,000 | 1,401,000 | 7,060,000 | 1,064,000 | 13,460,000 | 5,652,000 | -2,159,000 | ||
companies less than 5% owned | 23,442,000 | 28,128,000 | 26,390,000 | 28,563,000 | 147,519,000 | -256,000 | -19,635,000 | -725,000 | ||
total investment income | 35,365,000 | 42,986,000 | 39,145,000 | 46,097,000 | 41,465,000 | 40,646,000 | 34,833,000 | 36,309,000 | ||
expenses: | ||||||||||
management fees | 5,780,000 | 6,613,000 | 7,267,000 | 7,134,000 | ||||||
performance-based incentive fees | 4,633,000 | 5,407,000 | 4,814,000 | 6,380,000 | 3,607,750 | 5,565,000 | 3,591,000 | |||
interest and other credit facility expenses | 3,654,000 | 6,755,000 | 4,819,000 | 4,823,000 | -3,444,000 | 3,475,000 | 9,051,000 | 2,695,000 | ||
administrative services expense | 1,289,000 | 1,196,000 | 1,529,000 | 727,000 | ||||||
other general and administrative expenses | 1,067,000 | 1,387,000 | 1,460,000 | 1,514,000 | 520,000 | 2,011,000 | 995,000 | 1,009,000 | ||
total operating expenses | 16,423,000 | 21,358,000 | 19,889,000 | 20,578,000 | 10,015,000 | 18,328,000 | 20,438,000 | 14,953,000 | ||
income tax expense | -54,000 | 60,000 | 26,000 | 257,000 | ||||||
total expenses | 15,456,250 | 21,358,000 | 19,889,000 | 20,578,000 | ||||||
net investment income | 18,532,000 | 21,628,000 | 19,256,000 | 25,519,000 | 24,201,000 | 22,258,000 | 14,369,000 | 21,099,000 | ||
realized and unrealized gain on investments, foreign currencies and derivatives: | ||||||||||
net realized gain on investments: | ||||||||||
net realized gain on investments | -29,018,000 | -15,543,000 | 700,000 | -15,951,000 | 431,000 | -20,322,000 | 10,277,000 | |||
net realized loss on foreign currencies and derivatives: | -103,500 | -110,000 | -11,000 | |||||||
total net realized loss before income taxes | -27,549,000 | -15,653,000 | -1,912,000 | |||||||
net realized gain | -4,219,000 | -15,653,000 | 689,000 | -2,408,250 | 356,000 | 9,166,000 | ||||
net change in unrealized gain on investments | 37,980,000 | 5,904,000 | -18,263,000 | 8,568,000 | 19,286,000 | 18,834,000 | ||||
net change in unrealized gain on foreign currencies and derivatives | -16,000 | -1,309,000 | 906,000 | 1,030,000 | ||||||
net change in unrealized gain | 37,964,000 | 4,595,000 | -17,357,000 | 9,598,000 | 22,001,000 | 7,629,000 | 15,893,000 | |||
net realized and unrealized gain on investments, foreign currencies and derivatives | 10,415,000 | -11,058,000 | -19,269,000 | 10,287,000 | ||||||
net increase in net assets resulting from operations | 28,947,000 | 10,570,000 | -13,000 | 35,806,000 | 23,298,000 | 30,243,000 | 16,062,000 | 46,158,000 | ||
earnings per share | 0.65 | 0.24 | 0.81 | 0.59 | 0.82 | 0.44 | 1.26 | |||
net realized loss on investments | -1,619,000 | |||||||||
net realized gain on foreign currencies and derivatives: | -293,000 | |||||||||
net realized loss | -1,912,000 | -19,155,000 | ||||||||
total net realized gain before income taxes | 689,000 | |||||||||
other interest and dividend income | 22,357,000 | 26,382,000 | 27,819,000 | 35,227,000 | ||||||
investment advisory and management fees | 6,613,000 | 6,083,000 | 5,673,000 | 5,278,000 | ||||||
administrative services fees | 754,500 | 1,194,000 | 1,128,000 | |||||||
net investment income before income tax expense | 14,517,250 | 22,318,000 | 14,395,000 | 21,356,000 | ||||||
realized and unrealized gain on investments, derivatives and foreign currencies: | ||||||||||
net realized gain: | ||||||||||
investments: | ||||||||||
foreign currencies & derivatives | -4,750 | -860,000 | ||||||||
net realized gain before income taxes | -2,408,250 | -429,000 | 9,951,000 | |||||||
net change in unrealized gain: | ||||||||||
investments | 11,247,250 | 6,869,000 | ||||||||
net realized and unrealized gain on investments, derivatives and foreign currencies | 8,684,250 | 7,985,000 | 1,693,000 | 25,059,000 | ||||||
net realized loss: | ||||||||||
derivatives | 1,730,000 | -944,000 | ||||||||
foreign currencies | -563,000 | |||||||||
net realized loss before income taxes | -19,155,000 | |||||||||
total interest and dividends | 36,309,000 | |||||||||
performance-based incentive fee | 5,275,000 | |||||||||
administrative service fee | 696,000 | |||||||||
foreign currency exchange | 618,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2023-12-31 |
|---|---|---|---|---|
selected balance sheet information for sslp: | ||||
investments at fair value | 187,210,000 | 184,110,000 | 165,633,000 | |
cash and other assets | 24,311,000 | 26,843,000 | 30,602,000 | |
total assets | 211,521,000 | 210,953,000 | 196,235,000 | |
debt outstanding | 111,306,000 | 111,181,000 | 95,154,000 | |
distributions payable | 2,684,000 | 1,892,000 | 3,395,000 | |
interest payable and other credit facility related expenses | 429,000 | 444,000 | 465,000 | |
accrued expenses and other payables | 383,000 | 356,000 | 345,000 | |
total liabilities | 114,802,000 | 113,873,000 | 99,359,000 | |
members’ equity | 96,719,000 | 97,080,000 | 96,876,000 | |
total liabilities and members’ equity | 211,521,000 | 210,953,000 | 196,235,000 | |
selected income statement information for sslp: | ||||
interest income | 5,092,000 | 4,558,000 | 4,469,000 | |
service fees* | 116,000 | 109,000 | 105,000 | |
interest and other credit facility expenses | 2,263,000 | 2,248,000 | 2,242,000 | |
other general and administrative expenses | 57,000 | 61,000 | 71,000 | |
total expenses | 2,436,000 | 2,418,000 | 2,418,000 | |
net investment income | 2,656,000 | 2,140,000 | 2,051,000 | |
realized gain on investments | 21,000 | 14,000 | 323,000 | |
net change in unrealized gain on investments | -353,000 | -59,000 | -285,000 | |
net realized and unrealized gain on investments | -332,000 | -45,000 | 38,000 | |
net income | 2,324,000 | 2,095,000 | 2,089,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-03-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||
net increase in net assets resulting from operations | 23,305,000 | 24,232,000 | 19,926,000 | 27,871,000 | 26,947,000 | 18,995,000 | 6,824,000 | 13,528,000 | -15,646,000 | 1,463,000 | 13,371,000 | 18,567,000 | 21,510,000 | 18,617,000 | 19,631,000 | 24,832,000 | 18,130,000 | 19,790,000 | 20,048,000 | 17,163,000 | 18,783,000 | 17,158,000 |
adjustments to reconcile net increase in net assets resulting from operations to net cash from operating activities: | ||||||||||||||||||||||
net realized (gain) loss on investments and cash equivalents | -1,323,000 | -235,000 | 422,000 | 37,326,000 | 105,000 | -30,000 | 127,000 | -561,000 | 366,000 | -104,000 | 534,000 | -680,000 | -190,000 | -367,000 | 8,543,000 | 94,000 | -573,000 | |||||
net change in unrealized (gain) loss on investments | -356,000 | -2,388,000 | 1,757,000 | -3,884,000 | -30,799,000 | 35,835,000 | 12,045,000 | 1,508,000 | -2,487,000 | -6,410,000 | -6,128,000 | |||||||||||
deferred financing costs/market discount amortization | 774,000 | 737,000 | 758,000 | |||||||||||||||||||
net accretion of discount on investments | -1,745,000 | -1,868,000 | -1,604,000 | -2,355,000 | -3,465,000 | -3,360,000 | -2,490,000 | -2,991,000 | -3,229,000 | -1,540,000 | -1,561,000 | -1,437,000 | -1,654,000 | -2,140,000 | ||||||||
increase in operating assets: | ||||||||||||||||||||||
purchase of investments | -276,941,000 | -333,308,000 | -193,471,000 | -100,173,000 | -187,424,000 | -212,948,000 | -155,976,000 | -245,329,000 | -93,452,000 | -67,521,000 | -230,659,000 | -68,975,000 | -98,715,000 | -42,394,000 | -80,156,000 | -109,705,000 | -189,643,000 | -130,903,000 | -153,103,000 | -228,111,000 | -22,036,000 | -101,369,000 |
proceeds from disposition of investments | 311,835,000 | 208,941,000 | 194,902,000 | 127,860,000 | 207,375,000 | 122,538,000 | 144,686,000 | 80,662,000 | 78,142,000 | 100,980,000 | 106,572,000 | 149,832,000 | 65,514,000 | 60,054,000 | 90,394,000 | 71,454,000 | 181,798,000 | 200,712,000 | 142,856,000 | 55,464,000 | 128,928,000 | 83,347,000 |
capitalization of payment-in-kind income | -1,904,000 | -1,776,000 | -1,713,000 | -2,799,000 | -2,730,000 | -3,016,000 | -3,190,000 | -734,000 | -327,000 | -692,000 | ||||||||||||
collections of payment-in-kind income | 79,000 | 95,000 | 942,000 | 2,314,000 | 202,000 | 214,000 | 31,000 | 867,000 | ||||||||||||||
receivable for investments sold | -21,000 | 1,235,000 | 237,000 | -11,000 | -129,000 | -281,000 | -64,000 | -191,000 | -350,000 | 643,000 | -43,000 | 795,000 | -701,000 | -479,000 | 25,943,000 | -25,590,000 | -21,092,000 | 64,000 | 1,324,000 | -293,000 | 9,894,000 | -3,924,000 |
interest receivable | -2,572,000 | 1,182,000 | 348,000 | -1,097,000 | -757,000 | -564,000 | -801,000 | -1,072,000 | -1,140,000 | -723,000 | 879,000 | 356,000 | -397,000 | -430,000 | 1,910,000 | -802,000 | -2,428,000 | 964,000 | 666,000 | -956,000 | -643,000 | 2,181,000 |
dividends receivable | 1,993,000 | -377,000 | -2,048,000 | -24,000 | -239,000 | 0 | 438,000 | -899,000 | -1,642,000 | 27,000 | -9,000 | 498,000 | -1,581,000 | 188,000 | 1,202,000 | -852,000 | 3,027,000 | 1,537,000 | 704,000 | -2,055,000 | -1,000 | -642,000 |
prepaid expenses and other assets | 5,000 | -25,000 | -593,000 | -322,000 | 94,000 | -27,000 | -191,000 | 41,000 | 0 | -360,000 | 88,000 | 53,000 | -181,000 | 101,000 | 57,000 | -134,000 | 28,000 | 31,000 | 199,000 | 120,000 | 91,000 | -368,000 |
increase in operating liabilities: | ||||||||||||||||||||||
payable for investments and cash equivalents purchased | 24,431,000 | -98,170,000 | 49,564,000 | -39,421,000 | -643,000 | -92,020,000 | 7,609,000 | -79,960,000 | -230,958,000 | 259,829,000 | 71,531,000 | 75,226,000 | -29,997,000 | 5,313,000 | -49,920,000 | -1,868,000 | -5,351,000 | 75,327,000 | -4,873,000 | -199,898,000 | -60,402,000 | 150,086,000 |
management fee payable | 217,000 | 247,000 | -226,000 | -145,000 | 173,000 | 172,000 | -258,000 | 974,000 | -300,000 | -219,000 | 252,000 | 80,000 | 275,000 | 205,000 | 165,000 | 58,000 | -14,000 | -60,000 | -900,000 | 184,000 | -152,000 | -151,000 |
performance-based incentive fee payable | 14,000 | -146,000 | -397,000 | 42,000 | 108,000 | 114,000 | -23,000 | 1,395,000 | 3,376,000 | -1,864,000 | -3,182,000 | 13,000 | 3,075,000 | 0 | -8,000 | 3,000 | -187,000 | 77,000 | 54,000 | 346,000 | -100,000 | -329,000 |
administrative services expense payable | 1,456,000 | -3,783,000 | 752,000 | 314,000 | 1,512,000 | 1,417,000 | -739,000 | 337,000 | 436,000 | -2,169,000 | 1,171,000 | -14,000 | -951,000 | 932,000 | 1,118,000 | -2,393,000 | 403,000 | 1,368,000 | -2,460,000 | 536,000 | 1,119,000 | -2,852,000 |
interest payable | 260,000 | 462,000 | -1,796,000 | -622,000 | 479,000 | 410,000 | -1,416,000 | -27,000 | -952,000 | 3,570,000 | 3,040,000 | -3,172,000 | 3,307,000 | 3,009,000 | -692,000 | 693,000 | 3,551,000 | -1,294,000 | 2,026,000 | 2,517,000 | -2,186,000 | 1,834,000 |
other liabilities and accrued expenses | -509,000 | 89,000 | 381,000 | -623,000 | 926,000 | 256,000 | -615,000 | -1,019,000 | 2,122,000 | -503,000 | 7,000 | -118,000 | 173,000 | -651,000 | -219,000 | 70,000 | 56,000 | 1,377,000 | 782,000 | -396,000 | 105,000 | -309,000 |
net cash from operating activities | 78,998,000 | -204,856,000 | 68,141,000 | 7,339,000 | 39,367,000 | -163,982,000 | 9,503,000 | -227,922,000 | -225,054,000 | 304,230,000 | -38,484,000 | 167,888,000 | -48,081,000 | 36,407,000 | 3,544,000 | -50,857,000 | -11,846,000 | 168,345,000 | 6,823,000 | -355,659,000 | 70,632,000 | 143,966,000 |
capital expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
free cash flows | 78,998,000 | -204,856,000 | 68,141,000 | 7,339,000 | 39,367,000 | -163,982,000 | 9,503,000 | -227,922,000 | -225,054,000 | 304,230,000 | -38,484,000 | 167,888,000 | -48,081,000 | 36,407,000 | 3,544,000 | -50,857,000 | -11,846,000 | 168,345,000 | 6,823,000 | -355,659,000 | 70,632,000 | 143,966,000 |
cash flows from financing activities: | ||||||||||||||||||||||
cash distributions paid | -22,367,000 | -22,368,000 | -22,367,000 | -22,367,000 | -22,367,000 | -29,824,000 | -22,392,000 | -22,456,000 | -14,971,000 | -34,654,000 | -17,327,000 | -17,327,000 | -17,327,000 | -17,327,000 | -17,327,000 | -17,327,000 | -16,647,000 | -17,327,000 | -16,904,000 | -16,904,000 | -16,620,000 | -16,899,000 |
proceeds from unsecured borrowings | 124,280,000 | 0 | 49,820,000 | 0 | -54,000 | 134,968,000 | ||||||||||||||||
repayment of unsecured borrowings | 0 | 0 | -85,000,000 | 0 | 0 | -75,000,000 | 0 | |||||||||||||||
proceeds from secured borrowings | 134,582,000 | 252,000,000 | 244,474,000 | 104,997,000 | 267,695,000 | 234,000,000 | 166,000,000 | 405,488,000 | 280,979,000 | 57,425,000 | 258,000,000 | 53,000,000 | 146,000,000 | 0 | 78,179,000 | 296,400,000 | 125,269,000 | 140,000,000 | 130,700,000 | 228,000,000 | 126,700,000 | 97,500,000 |
repayment of secured borrowings | -293,823,000 | -119,000,000 | -202,334,000 | -126,000,000 | -289,500,000 | -137,000,000 | -62,000,000 | -255,900,000 | -102,100,000 | -196,000,000 | -260,260,000 | -94,000,000 | -112,000,000 | 0 | -112,800,000 | -176,800,000 | -171,900,000 | -211,900,000 | -126,800,000 | -53,000,000 | -201,700,000 | -212,700,000 |
net cash from financing activities | -57,328,000 | 110,632,000 | -15,407,000 | -43,370,000 | -44,172,000 | 67,176,000 | 6,598,000 | 127,132,000 | 13,854,000 | -38,261,000 | 30,751,000 | -57,924,000 | 17,067,000 | -17,049,000 | -51,755,000 | 102,406,000 | -2,079,000 | -89,132,000 | -12,912,000 | 158,123,000 | -91,592,000 | -32,072,000 |
net increase in cash and cash equivalents | 52,734,000 | -36,031,000 | -96,806,000 | 16,101,000 | -100,790,000 | -211,200,000 | 265,969,000 | -7,733,000 | 109,964,000 | -31,014,000 | 19,358,000 | -48,211,000 | 51,549,000 | -13,925,000 | 79,213,000 | -6,089,000 | -197,536,000 | -20,960,000 | 111,894,000 | |||
cash and cash equivalents at beginning of period | 0 | 0 | 414,271,000 | 344,154,000 | 0 | 0 | 428,333,000 | 0 | 0 | 322,935,000 | 0 | 0 | 388,776,000 | 0 | 0 | 207,216,000 | 0 | 0 | 150,789,000 | 0 | 0 | 312,046,000 |
cash and cash equivalents at end of period | 21,670,000 | -94,224,000 | 467,005,000 | 308,123,000 | -4,805,000 | -96,806,000 | 444,434,000 | -100,790,000 | -211,200,000 | 588,904,000 | -7,733,000 | 109,964,000 | 357,762,000 | 19,358,000 | -48,211,000 | 258,765,000 | -13,925,000 | 79,213,000 | 144,700,000 | -197,536,000 | -20,960,000 | 423,940,000 |
supplemental disclosure of cash flow information: | ||||||||||||||||||||||
cash paid for interest | 17,650,000 | 15,543,000 | 16,878,000 | 18,810,000 | 19,395,000 | 17,432,000 | 16,702,000 | 12,811,000 | 11,304,000 | 4,758,000 | 4,087,000 | 10,318,000 | 3,922,000 | 3,501,000 | 7,793,000 | 6,635,000 | 1,970,000 | 7,386,000 | 3,883,000 | 2,831,000 | 7,143,000 | 3,835,000 |
non-cash purchase and disposition of investments | ||||||||||||||||||||||
description | ||||||||||||||||||||||
senior secured loans — 126.0% | ||||||||||||||||||||||
first lien bank debt/senior secured loans | ||||||||||||||||||||||
33across inc. | ||||||||||||||||||||||
alkeme intermediary holdings, llc | ||||||||||||||||||||||
all states ag parts, llc | ||||||||||||||||||||||
baymark health services, inc. | ||||||||||||||||||||||
bayside opco, llc | ||||||||||||||||||||||
bayside parent, llc | ||||||||||||||||||||||
bdg media, inc. | ||||||||||||||||||||||
blazing star parent, llc | ||||||||||||||||||||||
cc sag holdings corp. | ||||||||||||||||||||||
clifford loan ventures, llc & clifford preferred ventures holdings llc | ||||||||||||||||||||||
copper river seafoods, inc. | ||||||||||||||||||||||
cvausa management, llc | ||||||||||||||||||||||
deepintent, inc. | ||||||||||||||||||||||
enhanced permanent capital, llc | ||||||||||||||||||||||
eyesouth eye care holdco llc | ||||||||||||||||||||||
fe advance, llc & sonic aca advance llc | ||||||||||||||||||||||
fertility (itc) investment holdco, llc | ||||||||||||||||||||||
human interest inc. | ||||||||||||||||||||||
icims, inc. | ||||||||||||||||||||||
infillion inc. | ||||||||||||||||||||||
insight investments holdings, llc | ||||||||||||||||||||||
kingsbridge holdings, llc | ||||||||||||||||||||||
logix holding company, llc | ||||||||||||||||||||||
luxury asset capital, llc | ||||||||||||||||||||||
lyneer staffing solutions, llc | ||||||||||||||||||||||
maxor acquisition, inc. | ||||||||||||||||||||||
ns and associates llc | ||||||||||||||||||||||
one touch direct, llc | ||||||||||||||||||||||
ons mso, llc | ||||||||||||||||||||||
pinnacle fertility, inc. | ||||||||||||||||||||||
plastic management, llc | ||||||||||||||||||||||
quantcast corporation | ||||||||||||||||||||||
rqm+ corp. | ||||||||||||||||||||||
sherwood management co., inc. | ||||||||||||||||||||||
shoes for crews global, llc | ||||||||||||||||||||||
sightly enterprises, inc. | ||||||||||||||||||||||
slr healthcare abl | ||||||||||||||||||||||
southern lifting and hoisting, llc | ||||||||||||||||||||||
southern orthodontic partners management, llc | ||||||||||||||||||||||
southern transport llc | ||||||||||||||||||||||
spar marketing force, inc. | ||||||||||||||||||||||
stella & chewy's, llc | ||||||||||||||||||||||
net decrease in cash and cash equivalents | ||||||||||||||||||||||
senior secured loans — 127.8% | ||||||||||||||||||||||
streamland media holdings llc | ||||||||||||||||||||||
sunmed group holdings, llc | ||||||||||||||||||||||
senior secured loans — 112.8% | ||||||||||||||||||||||
aegis toxicology sciences corporation | ||||||||||||||||||||||
peter c. foy & associates insurance services, llc | ||||||||||||||||||||||
rxsense holdings llc | ||||||||||||||||||||||
net realized gain on investments and cash equivalents | -135,000 | -687,000 | ||||||||||||||||||||
deferred financing costs/market discount | 549,000 | 526,000 | 511,000 | 524,000 | 622,000 | |||||||||||||||||
repurchase of common stock | 0 | 0 | -10,000 | |||||||||||||||||||
senior secured loans — 127.3% | ||||||||||||||||||||||
atria wealth solutions, inc. | ||||||||||||||||||||||
basic fun, inc. | ||||||||||||||||||||||
brainjolt llc | ||||||||||||||||||||||
crewline buyer, inc. | ||||||||||||||||||||||
ens holdings iii corp. & es opco usa llc | ||||||||||||||||||||||
foundation consumer brands, llc | ||||||||||||||||||||||
gsm acquisition corp. | ||||||||||||||||||||||
net realized loss on investments and cash equivalents | 278,000 | |||||||||||||||||||||
cash acquired in the mergers | ||||||||||||||||||||||
issuance of shares in connection with the mergers | ||||||||||||||||||||||
net change in unrealized loss on investments | 4,317,000 | 15,872,000 | ||||||||||||||||||||
cash acquired in merger | 0 | |||||||||||||||||||||
issuance of shares in connection with the merger | 0 | |||||||||||||||||||||
senior secured loans — 127.7% | ||||||||||||||||||||||
all state ag parts, llc | ||||||||||||||||||||||
american teleconferencing services, ltd.** | ||||||||||||||||||||||
amerimark intermediate holdings, llc(14)** | ||||||||||||||||||||||
apex services partners, llc | ||||||||||||||||||||||
composite technology acquisition corp. | ||||||||||||||||||||||
enverus holdings, inc. | ||||||||||||||||||||||
erie construction mid-west, llc | ||||||||||||||||||||||
higginbotham insurance agency, inc. | ||||||||||||||||||||||
high street buyer, inc. | ||||||||||||||||||||||
kaseya, inc. | ||||||||||||||||||||||
kid distro holdings, llc | ||||||||||||||||||||||
kore wireless group, inc. | ||||||||||||||||||||||
maurices, incorporated | ||||||||||||||||||||||
montefiore nyack hospital | ||||||||||||||||||||||
nspc intermediate corp. | ||||||||||||||||||||||
orthopedic care partners management, llc | ||||||||||||||||||||||
pediatric home respiratory services, llc | ||||||||||||||||||||||
phynet dermatology llc | ||||||||||||||||||||||
pinnacle treatment centers, inc. | ||||||||||||||||||||||
plastics management, llc | ||||||||||||||||||||||
ppt management holdings, llc | ||||||||||||||||||||||
rsc acquisition, inc. | ||||||||||||||||||||||
scp eye care, llc | ||||||||||||||||||||||
sho holding i corporation | ||||||||||||||||||||||
spar marketing force, inc | ||||||||||||||||||||||
stryten resources llc | ||||||||||||||||||||||
tauc management, llc | ||||||||||||||||||||||
tilley distribution, inc. | ||||||||||||||||||||||
ultimate baked goods midco llc | ||||||||||||||||||||||
united digestive mso parent, llc | ||||||||||||||||||||||
urology management holdings, inc. | ||||||||||||||||||||||
vessco midco holdings, llc | ||||||||||||||||||||||
world insurance associates, llc | ||||||||||||||||||||||
total first lien bank debt/senior secured loans | ||||||||||||||||||||||
second lien asset-based senior secured loans | ||||||||||||||||||||||
acres commercial mortgage, llc | ||||||||||||||||||||||
second lien bank debt/senior secured loans | ||||||||||||||||||||||
rd holdco, inc.** | ||||||||||||||||||||||
deferred financing costs | 427,000 | 372,000 | 403,000 | 394,000 | 278,000 | 193,000 | 133,000 | 133,000 | 95,000 | 92,000 | 27,000 | 28,000 | 27,000 | |||||||||
senior secured loans — 109.8% | ||||||||||||||||||||||
amerimark intermediate holdings, llc | ||||||||||||||||||||||
atria wealth solutions, inc | ||||||||||||||||||||||
basic fun, inc | ||||||||||||||||||||||
inszone mid, llc | ||||||||||||||||||||||
ivy fertility services, llc | ||||||||||||||||||||||
mmit holdings, llc | ||||||||||||||||||||||
nac holdings corporation | ||||||||||||||||||||||
rqm+ corp | ||||||||||||||||||||||
stryten energy llc | ||||||||||||||||||||||
usr parent, inc. | ||||||||||||||||||||||
varilease finance, inc. | ||||||||||||||||||||||
total second lien asset-based senior secured loans | ||||||||||||||||||||||
phymed management llc ** | ||||||||||||||||||||||
rug doctor llc | ||||||||||||||||||||||
total second lien bank debt/senior secured loans | ||||||||||||||||||||||
first lien life science senior secured loans | ||||||||||||||||||||||
alimera sciences, inc. | ||||||||||||||||||||||
arcutis biotherapeutics, inc. | ||||||||||||||||||||||
ardelyx, inc. | ||||||||||||||||||||||
axcella health inc. | ||||||||||||||||||||||
bridgebio pharma, inc. | ||||||||||||||||||||||
centrexion therapeutics, inc. | ||||||||||||||||||||||
cerapedics, inc. | ||||||||||||||||||||||
delphinus medical technologies, inc. | ||||||||||||||||||||||
glooko, inc. | ||||||||||||||||||||||
neuronetics, inc. | ||||||||||||||||||||||
omniguide holdings, inc. | ||||||||||||||||||||||
rezolute, inc | ||||||||||||||||||||||
rubius therapeutics, inc. | ||||||||||||||||||||||
scpharmaceuticals, inc. | ||||||||||||||||||||||
soc telemed, inc. | ||||||||||||||||||||||
vapotherm, inc. | ||||||||||||||||||||||
total first lien life science senior secured loans | ||||||||||||||||||||||
total senior secured loans | ||||||||||||||||||||||
net change in unrealized loss on debt | 1,500,000 | |||||||||||||||||||||
proceeds from issuance of unsecured debt | 0 | 0 | 100,000,000 | |||||||||||||||||||
senior secured loans — 105.4% | ||||||||||||||||||||||
alteon health, llc | ||||||||||||||||||||||
community brands parentco, llc | ||||||||||||||||||||||
legility, llc | ||||||||||||||||||||||
smile doctors llc | ||||||||||||||||||||||
the children’s place, inc. | ||||||||||||||||||||||
phymed management llc | ||||||||||||||||||||||
apollo endosurgery, inc. | ||||||||||||||||||||||
rezolute, inc. | ||||||||||||||||||||||
capitalization of payment-in-kind interest | -1,591,000 | -1,737,000 | -1,611,000 | -438,000 | -230,000 | -45,000 | -42,000 | -49,000 | -100,000 | -61,000 | -40,000 | |||||||||||
collections of payment-in-kind interest | 823,000 | 23,000 | 43,000 | 147,000 | 205,000 | 21,000 | 23,000 | 740,000 | 0 | 0 | 173,000 | |||||||||||
senior secured loans — 89.7% | ||||||||||||||||||||||
american teleconferencing services, ltd. | ||||||||||||||||||||||
sentry data systems, inc. | ||||||||||||||||||||||
kindred biosciences, inc. | ||||||||||||||||||||||
si-bone, inc. | ||||||||||||||||||||||
senior secured loans — 98.1% | ||||||||||||||||||||||
aviatorcap sii, llc | ||||||||||||||||||||||
high street insurance partners, inc. | ||||||||||||||||||||||
pet holdings ulc & pet supermarket, inc. | ||||||||||||||||||||||
greystone select holdings llc & greystone & co., inc. | ||||||||||||||||||||||
genmark diagnostics, inc. | ||||||||||||||||||||||
pq bypass, inc. | ||||||||||||||||||||||
other receivables | ||||||||||||||||||||||
senior secured loans —87.9% | ||||||||||||||||||||||
enhanced capital group, llc | ||||||||||||||||||||||
pinnacle treatment centers, inc | ||||||||||||||||||||||
sentry data systems, inc | ||||||||||||||||||||||
soleo health holdings, inc | ||||||||||||||||||||||
bishop lifting products, inc. | ||||||||||||||||||||||
atyr pharma, inc. | ||||||||||||||||||||||
cardiva medical, inc. | ||||||||||||||||||||||
senior secured loans — 88.5% | ||||||||||||||||||||||
altern marketing, llc | ||||||||||||||||||||||
solara medical supplies, inc. | ||||||||||||||||||||||
net change in unrealized gain on investments and cash equivalents | -1,095,000 | -6,902,000 | ||||||||||||||||||||
senior secured loans — 92.4% | ||||||||||||||||||||||
bank debt/senior secured loans | ||||||||||||||||||||||
bam capital, llc | ||||||||||||||||||||||
falmouth group holdings corp. | ||||||||||||||||||||||
global holdings llc & payment concepts llc | ||||||||||||||||||||||
ihs intermediate, inc. | ||||||||||||||||||||||
on location events, llc & primesport holdings inc. | ||||||||||||||||||||||
pskw, llc & pdr, llc | ||||||||||||||||||||||
rs energy group u.s., inc. | ||||||||||||||||||||||
soint, llc | ||||||||||||||||||||||
other receivable | -230,000 | 59,000 | -332,000 | -3,000 | -1,000 | |||||||||||||||||
senior secured loans — 92.0% | ||||||||||||||||||||||
amerilife group, llc | ||||||||||||||||||||||
associated pathologists, llc | ||||||||||||||||||||||
net realized gain on foreign currencies | ||||||||||||||||||||||
net change in unrealized (gain) loss on investments and cash equivalents | 966,000 | -435,000 | -824,000 | -8,390,000 | -2,798,000 | -256,000 | ||||||||||||||||
net change in unrealized loss on foreign currencies | ||||||||||||||||||||||
effect of consolidation of senior secured unitranche loan program llc | ||||||||||||||||||||||
consolidation of sslp facility and sslp ii facility | ||||||||||||||||||||||
senior secured loans — 84.3% | ||||||||||||||||||||||
datto, inc. | ||||||||||||||||||||||
global tel*link corporation | ||||||||||||||||||||||
k2 pure solutions nocal, l.p. | ||||||||||||||||||||||
net realized (gain) loss on foreign currencies | 0 | 1,000 | ||||||||||||||||||||
senior secured loans — 69.8% | ||||||||||||||||||||||
empower payments acquisition, inc. | ||||||||||||||||||||||
mri software llc | ||||||||||||||||||||||
radiology partners, inc. | ||||||||||||||||||||||
salient partners, l.p. | ||||||||||||||||||||||
southern auto finance company | ||||||||||||||||||||||
the octave music group, inc. | ||||||||||||||||||||||
total bank debt/senior secured loans | ||||||||||||||||||||||
senior secured loans — 81.0% | ||||||||||||||||||||||
accentcare, inc. | ||||||||||||||||||||||
disa holdings acquisition subsidiary corp. | ||||||||||||||||||||||
senior secured loans — 76.4% | ||||||||||||||||||||||
american teleconferencing services, ltd. (pgi) (12). | ||||||||||||||||||||||
argo turboserve corporation & argo tech, llc †† | ||||||||||||||||||||||
aviatorcap sii, llc i | ||||||||||||||||||||||
bishop lifting products, inc. (12). | ||||||||||||||||||||||
datapipe, inc. | ||||||||||||||||||||||
easyfinancial services, inc. | ||||||||||||||||||||||
life science senior secured loans | ||||||||||||||||||||||
achaogen, inc. | ||||||||||||||||||||||
breathe technologies, inc. | ||||||||||||||||||||||
cardiodx, inc. | ||||||||||||||||||||||
cardiofocus, inc. | ||||||||||||||||||||||
cas medical systems, inc. | ||||||||||||||||||||||
cianna medical, inc. | ||||||||||||||||||||||
clinical ink, inc. | ||||||||||||||||||||||
conventus orthopaedics, inc. (12). | ||||||||||||||||||||||
lumeris solutions company, llc | ||||||||||||||||||||||
mitralign, inc. | ||||||||||||||||||||||
nabsys 2.0 llc | ||||||||||||||||||||||
rapid micro biosystems, inc. | ||||||||||||||||||||||
scynexis, inc. | ||||||||||||||||||||||
sentreheart, inc. | ||||||||||||||||||||||
sunesis pharmaceuticals, inc. | ||||||||||||||||||||||
trevi therapeutics, inc. | ||||||||||||||||||||||
total life science senior secured loans | ||||||||||||||||||||||
bank debt/senior secured loans — 79.1% | ||||||||||||||||||||||
agamatrix, inc. | ||||||||||||||||||||||
airxpanders, inc. | ||||||||||||||||||||||
conventus orthopaedics, inc. | ||||||||||||||||||||||
direct buy inc.(12)** †† | ||||||||||||||||||||||
island medical management holdings, llc | ||||||||||||||||||||||
tmk hawk parent, corp. | ||||||||||||||||||||||
touchtunes interactive networks, inc. | ||||||||||||||||||||||
net change in unrealized gain on foreign currencies | ||||||||||||||||||||||
bank debt/senior secured loans — 87.8% | ||||||||||||||||||||||
accentcare, inc | ||||||||||||||||||||||
agamatrix, inc | ||||||||||||||||||||||
argo turboserve corporation & argo tech, llc†† | ||||||||||||||||||||||
atyr pharma, inc | ||||||||||||||||||||||
axcella health inc | ||||||||||||||||||||||
breathe technologies, inc | ||||||||||||||||||||||
cardiodx, inc | ||||||||||||||||||||||
cardiofocus, inc | ||||||||||||||||||||||
cardiva medical, inc | ||||||||||||||||||||||
cas medical systems, inc | ||||||||||||||||||||||
cianna medical, inc | ||||||||||||||||||||||
clinical ink, inc | ||||||||||||||||||||||
conventus orthopaedics, inc | ||||||||||||||||||||||
datapipe, inc | ||||||||||||||||||||||
direct buy inc.**†† | ||||||||||||||||||||||
disa holdings acquisition subsidiary corp | ||||||||||||||||||||||
entegrion, inc | ||||||||||||||||||||||
ihs intermediate, inc | ||||||||||||||||||||||
inmar acquisition sub, inc | ||||||||||||||||||||||
k2 pure solutions nocal, l.p | ||||||||||||||||||||||
kore wireless group, inc | ||||||||||||||||||||||
mitralign, inc | ||||||||||||||||||||||
salient partners, l.p | ||||||||||||||||||||||
scynexis, inc | ||||||||||||||||||||||
sentreheart, inc | ||||||||||||||||||||||
tierpoint, llc | ||||||||||||||||||||||
touchtunes interactive networks, inc | ||||||||||||||||||||||
trevi therapeutics, inc | ||||||||||||||||||||||
u.s. anesthesia partners inc. | ||||||||||||||||||||||
vapotherm, inc | ||||||||||||||||||||||
varilease finance, inc | ||||||||||||||||||||||
subordinated debt/corporate notes — 3.1% | ||||||||||||||||||||||
alegeus technologies holdings corp | ||||||||||||||||||||||
preferred equity — 1.6% | ||||||||||||||||||||||
soagg llc | ||||||||||||||||||||||
total preferred equity |
